FDA says Pfizer COVID vaccine looks effective for young kids
Advisers to the FDA will publicly debate the evidence next week
NEW YORK, NEW YORK - OCTOBER 03: In this photo illustration, a medical syringe and vials of the Pfizer US pharmaceutical corporation and BioNTech German biotechnology 2021 company logos are seen on October 03, 2021 in New York City. Pfizer and BioNTech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as the media reported on 18 November 2020.
Photo credit Getty Images